Press Releases

Featured Press Releases

BIO Statement on Passage of the Reconciliation…

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on passage of the One, Big, Beautiful Bill Act (OBBBA):“The OBBBA contains important bipartisan provisions…

Learn more

Massachusetts Governor Maura Healey Named BIO’s…

Annual award honors governors for their leadership and commitment to strengthening biotechnology in their state BOSTON (June 17, 2025) – Today, the Biotechnology Innovation Organization (BIO) named Massachusetts Governor Maura Healey…

Learn more

BIO Elects Genentech’s Fritz Bittenbender as New…

Industry veteran takes the helm as Dr. Ted Love concludes two-year term marked by strategic growth and transition BOSTON (June 16, 2025) – Today, the Biotechnology Innovation Organization (BIO) announced that Fritz Bittenbender,…

Learn more

BIO Releases New Report Underscoring the Massive Economic Power of the American Bioeconomy

March 24, 2025

WASHINGTON D.C. – Today, the Biotechnology Innovation Organization (BIO), in partnership with Kearney, a global management consulting firm, released a first-of-its-kind report that assesses the significant economic impact of the U.S. bioeconomy…

BIO Applauds Introduction of Bipartisan Bill to Eliminate the Pill Penalty

February 25, 2025

Legislation will help spur the development of lifesaving treatments and cures WASHINGTON D.C. (February 25, 2025) – John Crowley, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement…

BIO Applauds Introduction of Bipartisan ORPHAN Cures Act

February 5, 2025

Urges Congress to support rare disease patients & support the billWASHINGTON, D.C. (February 5, 2025) – John F. Crowley, President & CEO of the Biotechnology Innovation Organization (BIO), today released the following statement after…

BIO Statement on New List of Medicines Targeted for Government Price Setting

January 17, 2025

WASHINGTON, D.C. (January 17, 2025) – The Biotechnology Innovation Organization (BIO) today released the following statement after the Biden administration released a list of 15 medicines being selected for government price setting:“In the final…

BIO Statement on the USMCA Biotech Corn Dispute Panel’s Final Ruling

December 20, 2024

Today the dispute settlement panel formed under the United States-Mexico-Canada Agreement (USMCA) issued a final ruling related to Mexico's restrictions on the importation of genetically modified (GM) corn. In response, John Crowley, President…

BIO Applauds the Inclusion of Important Health Care and Agriculture Priorities and Programs in Year-end Government Funding Bill

December 17, 2024

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), today released the following statement ahead of an expected vote in the U.S. House of Representatives on a year-end government funding bill that includes many…

BIO Appoints Veteran Communications Leader Sarah Alspach as Executive Vice President and Chief Communications Officer

December 9, 2024

Today, the Biotechnology Innovation Organization (BIO) named Sarah Alspach as its new executive vice president and chief communications officer. Alspach, a communications veteran, will join BIO’s senior leadership team. Her first day will be…

New Report Finds Bioscience Sector Generates Over $3 Trillion for U.S. Economy

December 2, 2024

Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry's economic performance, its impacts, and its geographic…

BIO Statement Regarding Nomination of Robert F. Kennedy Jr.

November 14, 2024

BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…

BIO Released the Following Statement After Yesterday’s Announcement From the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) Sharing Its Final Notice Exemption for Additional Modification Plants

November 13, 2024

“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.